Former Merck Executive Joins Board of Clinical Information Network, Inc.
SCOTTSDALE, Ariz., March 19 /PRNewswire/ -- Clinical Information Network, Inc., the Video Detailing company, announced today that Robert J. LaBuda has joined its board of directors.
Until establishing his own company in late 2008, LaBuda was the executive at Merck responsible for the successful deployment and expansion of their industry-leading Video Detailing initiative, as well as being responsible for Merck's Inside Sales & Customer Services.
"Bob brings considerable strategic insights to our Board of Directors. His 28 years of pharmaceutical industry sales and marketing experience, plus his in-depth knowledge and leadership in the successful deployment of Video Detailing, makes him an exceptional addition to our Board. He is a true pioneer in the use of alternative channels to access and communicate with physicians," stated Peter Moriarty, Clinical Information Network's CEO and Chairman.
"I am delighted to be joining the Board of Clinical Information Network," commented LaBuda. "I look forward to working with my fellow Directors in helping to guide the company, as it accelerates its growth towards market leadership in the field of Video Detailing. The company's products are clearly superior to any others currently available," he concluded.
About Clinical Information Network, Inc.:
Clinical Information Network, Inc. is a privately held company based in Scottsdale, Arizona. The company is focused on providing innovative communication systems and services to the healthcare industry. Its mission is to provide healthcare professionals with convenient access to multiple sources of clinical information that can assist them in further enhancing the standard of care delivered to patients. Their communication channels include state-of-the-art, yet easy to use, videoconferencing software that physicians can use on their desktops or laptop computers to contact other healthcare professionals, medical institutions, and pharmaceutical companies. For more information, contact 480.422.1811, or visit ... www.ClinicalinfoNet.com
Return to Press Releases